Publications by authors named "M S Shabeena Banu"

Background: Globally, 10% of pregnant women and 13% of postpartum women experience mental disorders. In Bangladesh, nearly 50% of mothers face common mental disorders, but mental health services and trained professionals to serve their needs are scarce. To address this, the government of Bangladesh's Non-Communicable Disease Control program initiated "Wellbeing Centers," telemental health services in selected public hospitals.

View Article and Find Full Text PDF

Lichen-associated endophytic Actinobacteria, particularly Streptomyces species, are recognized for their production of bioactive secondary metabolites with significant pharmaceutical potential. With the escalating prevalence of diseases, Streptomyces species are being investigated for its natural source of antimicrobial compounds for new antibiotics. This study focuses on the bioactive properties of secondary metabolites from lichen-associated endophytic Actinobacteria, focusing on Streptomyces glaucescens NTSB-37 isolated form lichen, Parmotrema perlatum (Huds.

View Article and Find Full Text PDF

Context: Dentin biomodification has been emphasized as a means of improving the bond between composite resin and tooth surface, consequently enhancing its longevity.

Aim: To evaluate the shear bond strength (SBS) of dentin after pretreatment with 2% chlorhexidine (CHX), 2% chitosan, nonthermal atmospheric plasma (NTAP), proanthocyanidins (5% pine bark ((PB) and 5% bromelain).

Settings And Design: The study was designed as an investigation.

View Article and Find Full Text PDF

Context: Effective use of nonthermal atmospheric plasma (NTAP) to strengthen adhesive-dentin interfacial bonding while disinfecting with chlorhexidine (CHX).

Aim: NTAP application at different time intervals on the dentinal shear bond strength (SBS) after pretreatment with 2% CHX as a cavity disinfectant.

Settings And Design: The design of the study was an study.

View Article and Find Full Text PDF

Glioma cells hijack developmental programs to control cell state. Here, we uncover a glioma cell state-specific metabolic liability that can be therapeutically targeted. To model cell conditions at brain tumor inception, we generated genetically engineered murine gliomas, with deletion of p53 alone (p53) or with constitutively active Notch signaling (N1IC), a pathway critical in controlling astrocyte differentiation during brain development.

View Article and Find Full Text PDF